The investment management industry's concerns over pharmaceutical stocks have heightened in recent day, due almost exclusively to the $253 million a Brazario County, Texas, jury awarded the widow of the man who died after taking Vioxx, a prescription painkiller.

The stock value of Merck, the Whitehouse Station, N.J.-based pharmaceutical giant that makes Vioxx, is expected to only decrease and a ripple effect might felt across the sector, experts say in an Aug. 22 report from Reuters.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.